Marothi P. Letsoalo

Durban, ZN, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Cervicovaginal microbiome diversity was not associated with mucosal pharmacokinetics of systemically delivered HIV broadly neutralizing antibodies.

Cervicovaginal microbiome diversity was not associated with mucosal pharmacokinetics of systemically delivered HIV broadly neutralizing antibodies.

Journal: Scientific reports

Published: January 29, 2026

Population pharmacokinetics of tenofovir alafenamide delivered via an annual subdermal implant in South African women.

Population pharmacokinetics of tenofovir alafenamide delivered via an annual subdermal implant in South African women.

Journal: Scientific reports

Published: November 12, 2025

Combined impact of recent sexual activity and vaginal product use on genital immune activation in South African women: implications for HIV risk.

Combined impact of recent sexual activity and vaginal product use on genital immune activation in South African women: implications for HIV risk.

Journal: Scientific reports

Published: September 11, 2025

Impact of STI and BV co-infection on genital cytokine profiles in postpartum women living with HIV on ART.

Impact of STI and BV co-infection on genital cytokine profiles in postpartum women living with HIV on ART.

Journal: Journal of reproductive immunology

Published: September 07, 2025

Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.

Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 05, 2025

Circulating Short-Chain Fatty Acids: Association with Vaginal Microbiota, Genital Inflammation, and HIV Acquisition.

Circulating Short-Chain Fatty Acids: Association with Vaginal Microbiota, Genital Inflammation, and HIV Acquisition.

Journal: AIDS research and human retroviruses

Published: August 18, 2025

Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.

Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.

Journal: The lancet. HIV

Published: April 16, 2025

Population pharmacokinetics of weight-based compared with fixed dosing of CAP256V2LS, a broadly neutralizing antibody for HIV prevention in women.

Population pharmacokinetics of weight-based compared with fixed dosing of CAP256V2LS, a broadly neutralizing antibody for HIV prevention in women.

Journal: The Journal of antimicrobial chemotherapy

Published: January 10, 2025

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB.

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB.

Journal: BMJ open

Published: November 28, 2024

Evaluation of Metronidazole Resistance of Vaginal Swab Isolates from South African Women Treated for Bacterial Vaginosis.

Evaluation of Metronidazole Resistance of Vaginal Swab Isolates from South African Women Treated for Bacterial Vaginosis.

Journal: Antibiotics (Basel, Switzerland)

Published: November 13, 2024

Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study.

Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study.

Journal: The lancet. HIV

Published: June 21, 2024

Corrigendum: An in vitro study to elucidate the effects of Product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors.

Corrigendum: An in vitro study to elucidate the effects of Product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors.

Journal: Frontiers in pharmacology

Published: March 15, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026